Edition:
United States

Biomerieux SA (BIOX.PA)

BIOX.PA on Paris Stock Exchange

74.00EUR
20 Jul 2018
Change (% chg)

€0.30 (+0.41%)
Prev Close
€73.70
Open
€73.60
Day's High
€74.20
Day's Low
€73.60
Volume
3,664
Avg. Vol
126,702
52-wk High
€82.20
52-wk Low
€59.00

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Underperform 0.93 December 20 Jul 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 1 1 2 2
(3) HOLD 6 6 6 6
(4) UNDERPERFORM 2 2 3 3
(5) SELL 3 3 2 2
No Opinion 0 0 0 0
Mean Rating 3.58 3.58 3.38 3.38

Consensus Estimates Analysis

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 1 1,219.30 1,219.30 1,219.30 1,273.90
Quarter Ending Jun-19 1 1,234.50 1,234.50 1,234.50 --
Year Ending Dec-18 11 2,393.85 2,435.00 2,364.36 2,512.69
Year Ending Dec-19 12 2,571.62 2,658.00 2,507.00 2,734.22
Earnings (per share)
Quarter Ending Dec-18 1 0.93 0.93 0.93 1.09
Quarter Ending Jun-19 1 1.10 1.10 1.10 --
Year Ending Dec-18 12 1.97 2.22 1.82 2.12
Year Ending Dec-19 13 2.33 2.64 2.09 2.44
LT Growth Rate (%) 2 12.95 13.40 12.50 25.50

Historical Surprises

No historical surprise data available.

Consensus Estimates Trend

Sales and Profit Figures in Euro (EUR)
Earnings and Dividend Figures in Euro (EUR)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-18 1,219.30 1,227.70 1,227.70 1,227.70 1,273.90
Quarter Ending Jun-19 1,234.50 -- -- -- --
Year Ending Dec-18 2,393.85 2,392.37 2,416.46 2,416.46 2,512.69
Year Ending Dec-19 2,571.62 2,570.36 2,593.71 2,593.71 2,734.22
Earnings (per share)
Quarter Ending Dec-18 0.93 1.08 1.08 1.08 1.09
Quarter Ending Jun-19 1.10 -- -- -- --
Year Ending Dec-18 1.97 1.97 2.01 2.02 2.12
Year Ending Dec-19 2.33 2.32 2.35 2.35 2.44

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-18 0 1 0 1
Quarter Ending Jun-19 -- -- -- --
Year Ending Dec-18 1 1 1 1
Year Ending Dec-19 1 1 1 1
Earnings
Quarter Ending Dec-18 0 1 0 1
Quarter Ending Jun-19 -- -- -- --
Year Ending Dec-18 0 2 0 2
Year Ending Dec-19 1 1 1 1